We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
+7.25%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$17B
AUM Growth
+$1.75B
Cap. Flow
+$808M
Cap. Flow %
4.76%
Top 10 Hldgs %
16.45%
Holding
2,292
New
159
Increased
1,096
Reduced
891
Closed
119
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYBT icon
1651
Stock Yards Bancorp
SYBT
$2.61B
$731K ﹤0.01%
14,374
-72
-0.5% -$3.72K
CNST
1652
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$728K ﹤0.01%
+21,553
New +$549K
HOLI
1653
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$726K ﹤0.01%
48,697
+17,107
+54% +$231K
UVV icon
1654
Universal Corp
UVV
$1.27B
$725K ﹤0.01%
12,724
+5,118
+67% +$295K
TPTX
1655
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$724K ﹤0.01%
9,283
+1,217
+15% +$89.9K
EGRX
1656
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$722K ﹤0.01%
+16,871
New +$696K
IWD icon
1657
iShares Russell 1000 Value ETF
IWD
$83.2B
$719K ﹤0.01%
4,533
-14,868
-77% -$2.35M
CLDR
1658
DELISTED
Cloudera, Inc.
CLDR
$719K ﹤0.01%
+45,365
New +$617K
VLT icon
1659
Invesco High Income Trust II
VLT
$65.4M
$718K ﹤0.01%
48,047
+14,315
+42% +$204K
APOG icon
1660
Apogee Enterprises
APOG
$900M
$716K ﹤0.01%
17,591
+7,066
+67% +$266K
SIGI icon
1661
Selective Insurance
SIGI
$5.77B
$715K ﹤0.01%
8,814
-1,587
-15% -$121K
WAL icon
1662
Western Alliance Bancorporation
WAL
$8.87B
$714K ﹤0.01%
7,690
+4,478
+139% +$444K
CRI icon
1663
Carter's
CRI
$1.48B
$706K ﹤0.01%
+6,841
New +$697K
SSP icon
1664
E.W. Scripps
SSP
$270M
$705K ﹤0.01%
34,560
+13,894
+67% +$291K
FTCH
1665
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$703K ﹤0.01%
13,955
+1,042
+8% +$49.4K
HOME
1666
DELISTED
At Home Group Inc.
HOME
$702K ﹤0.01%
+19,046
New +$649K
HAYN
1667
DELISTED
Haynes International, Inc.
HAYN
$699K ﹤0.01%
19,750
+7,948
+67% +$260K
RXRAW
1668
DELISTED
RXR Acquisition Corp. Warrants to purchase Class A common stock
RXRAW
$699K ﹤0.01%
+652,034
New +$535K
LDL
1669
DELISTED
Lydall, Inc.
LDL
$698K ﹤0.01%
+11,541
New +$444K
QADA
1670
DELISTED
QAD Inc.
QADA
$697K ﹤0.01%
+8,014
New +$585K
PRGS icon
1671
Progress Software
PRGS
$1.71B
$696K ﹤0.01%
+15,056
New +$682K
KIN
1672
DELISTED
Kindred Biosciences, Inc.
KIN
$696K ﹤0.01%
+75,923
New +$442K
CCRN
1673
DELISTED
Cross Country Healthcare
CCRN
$695K ﹤0.01%
42,077
+16,916
+67% +$258K
ABCB icon
1674
Ameris Bancorp
ABCB
$5.92B
$694K ﹤0.01%
13,698
+5,653
+70% +$304K
EDF
1675
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$168M
$693K ﹤0.01%
81,107
+31,820
+65% +$270K

Similar funds

Guggenheim Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Guggenheim Capital held 2,292 positions worth $17B, up 12% from $15.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Guggenheim Capital deployed $808M of net new capital in Q2 2021, opening 159 new positions and adding to 1,096 existing holdings. Its largest new stake was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was RXR Acquisition Corp. Units, an estimated $32.6M trimmed.

  • Guggenheim Capital's largest Q2 2021 buy was KKR Acquisition Holdings I Corp.: 15,278,818 shares worth $150M.
  • Guggenheim Capital added most to Apple in Q2 2021, an estimated $49.1M increase.
  • Guggenheim Capital's biggest Q2 2021 reduction was RXR Acquisition Corp. Units, cutting an estimated $32.6M.
  • Guggenheim Capital fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q2 2021, selling an estimated $153M.
  • Guggenheim Capital's ten largest holdings make up 16% of its $17B portfolio in Q2 2021.
  • Guggenheim Capital opened 159 new positions and closed 119 in Q2 2021.
  • Guggenheim Capital's portfolio value rose 12% quarter-over-quarter to $17B.

Based on Guggenheim Capital's 13F filing for Q2 2021, filed 13 Aug 2021.